Background and Aims: Investigating the impact of percutaneous transluminal angioplasty (PTA) on clinical status and health related quality of life in patients with claudication and critical limb ischaemia (CLI). Material and Methods: 61 patients and 64 limbs underwent aprimary PTA(30 claudication and 34 CLI cases). Clinical status was graded according to Ahn and Rutherford anda nkle/brachiali ndex (ABI). Qualityo fl ife wasa ssessedu sing theN ottingham Health Profile (NHP) preoperatively,one month and one year after the procedure. Tr iplex scan evaluation of the treated arterial segment was carried out postoperatively and one year after the procedure. Results: Claudication: 24/27 patients underwent one-year follow up, after which 20/24 had no claudication. In triplex evaluation 17 (63.0%) treated segments were open with 0-50% restenosis, 9( 33.3%) with 51-99% restenosis and one (3.7%) was occluded. CLI: 13/34 (38.2%) patients underwent one-year follow-up after which eight patients (61.5%) were asymptomatic and five (38.1%) had claudication. In triplex evaluation there was 0-50% restenosis in 6( 46.2%) segments treated with PTAa nd 51-99% restenosis in 7 (53.8%) segments. 21 (61.8%) patients did not conclude the one year follow up: 7 had died, 5had undergone bypass surgery and 6anamputation and 3did not attend the follow-up up for unknown reasons. Quality of life: For CLI patients, improvement was observed in the domain of pain, which continued throughout the follow-up period. Among the claudicants, the domain of physical mobility was improved at one month'sf ollow-up, but this effect disappeared during the following year and could not be seen at one the one-year follow-up. Conclusions: Te chnical success and one-year results in claudication are good, and the rate of complications is low.However,although PTAresulted in an immediate improvement in the quality of life, this effect was not seen in the long term. In critical limb Impact of endovascular treatment on clinical status and health-related quality of life ischemia there was agroup of patients in whom PTAled to asignificant benefit in terms of limb salvage and quality of life.
INTRODUCTION
Endovascular treatment of chronic lower limb ischemia is less invasive and usually achievable at the time of angiography.Patients with claudication often have smaller atherosclerotic manifestations than those with critical limb ischemia (CLI), and moderate lesions can often be treated with percutaneous transluminal angioplasty (PTA). In patients with CLI and widespread atherosclerotic lesions, endovascular treatment is rarely possible and bypass reconstruction is usually preferred. However,the risks of open surgery areunacceptable for some patients. In these cases, PTAmay offer an alternative for avoiding amputation. The crucial question is, what the effectiveness and patency of PTAisi nt he long term. Does it prevent amputations in patients with critical limb ischemia or increase the quality of life for ac laudicants?
The impact of PTAont he quality of life (QoL) of claudicants has been indefinite (1), and the QoL studies with CLI patients areb ased mainly on bypass surgery treatments (2). Moreover,t he success of intervention has been described in terms of graft patency and limb salvage (3).
In this prospective, nonrandomized study,weanalyse the haemodynamic results of PTA, and evaluate the quality of life of the patients beforeand after the PTAprocedure.
MATERIAL AND METHODS
Atotal of 61 consecutive patients and 64 limbs underwent aprimary PTAprocedureinateaching hospital of an academic institution during aperiod of 18 months. The study was approved by the local ethics committee, and written consent to participate was obtained in all cases. Data were collected prospectively.C linical criteria for categories of chronic limb ischemia wereoutlined according to Ahn and Rutherford(4) . Theclinical grades I(claudication), II (ischemic rest pain) and III (tissue loss) account for the different natural histories of each group. Ankle/brachial index (ABI) was used as an oninvasive hemodynamic assessment together with triplex scan evaluation performed immediately and one year after the PTAprocedure. Quality of life was assessed using the Nottingham Health Profile (NHP) developed by Hunt and McEwen (5) , and the Finnish version wasemployed in this study (6). The NHP is atwo-part instrument, and part Iwas used. The 38 yes/no items reflect thepatient's degree of distress within the domains of pain, physical mobility,emotional reactions, energy,social isolation and sleep. The answer is given as as coreb etween 0 and 100 describing the degree of harm in each item. The NHP questionnairewas filled out beforethe PTAprocedure as well as one month and one year after the procedure.
The clinical characteristics of patients ares ummarized in Tables 1and 2. The data werestatistically analysed using the SPSS software. Mean values of the variables between claudicants and CLI patients werec ompared using the independent samples t-test or the Mann-Whitney test. The means of the preoperative, 30-days follow-up and one-year follow-up values werecompared using thedependent samples t-test or the Wilcoxontest and general linear models for repeated measures.
ENDOVASCULAR TECHNIQUE
All interventions werep erformed under local anaesthesia using the standardized technique. Access to the iliac lesions was obtained via an ipsilateral retrograde punctureo ft he common femoral artery and to the femoropopliteal and crural lesionsv ia an ipsilateral antegrade puncture. The sheet was always used. Intravenous heparin (5000 units) was administered prior to the PTA. Technical success was defined as residual stenosis with less than 30% lumen reduction. Stents wereused in 22 of the 25 iliac lesions, half of which weres elf-expandable nitinol and the remaining half balloon-expandable stainless steel stents. In 2o f1 5 femoral lesions, nitinol stents wereused due to unsatisfactory primary results with ab alloon. All patients received aspirin (100 mg daily) after the procedure. The vessels weree xamined after revascularization with Color Flow Duplex sonography.T he site of the PTAa nd stentwas located with colour and the grade of the residual stenosis was measured. In addition, the haemodynamic status was analysed with pulsed wave Doppler sonography,and the possible residual stenosis was estimated using thepeak flow and the Doppler waveform. The examination was carried out by two independent radiologists who did not participate in the PTAprocedures.
RESULTS

CLAUDICATION
Twenty-seven claudication patients and 30 limbs weret reated, with am ean preoperative ABI of 0.63. The mean age of the claudication patients was 69.3 years (SD 10.7). One patient sustained acomplication (1/27, 3.3%), stroke, the day of the PTA. All limbs underwent triplex-ultrasound after the PTA. 20/30 (66.7%) of the treated areas wereo pen with 0-50% residual stenosis, and 10 limbs had residual stenosis of 51-99%. None of the sections treated wereo ccluded. 26 patients underwent a3 0-day clinical follow-up. One patient did not arrive at the 30-day control but did attend the one-year control with no claudication, the treated segment open with 0-50% restenosis and ABI 1.02 in the treated limb. At 30 days, 22/26 (84.6%) patients with atotal of 27 treated limbs had no claudication, and 3/26 (11.5%) had claudication. The mean ABI in patients who underwent 30day follow-up increased from the preoperative 0.63 to 0.84. 24 patients and 27 treated limbs underwent one-year follow-up, including ac linical control visit and triplex-ultrasound: 21/24 (87.5%) had no claudication, and 3/24 (12.5%) had claudication which had been present throughout the one-year follow-up period. Triplex ultrasound showed that 17/27 (63.0%) controlled sections wereopenwith 0-50% restenosis, 9/27 (33.3%) wereobserved to have 51-99% restenosis, and 1/27 (3.7%) PTAsegment was occluded. The mean ABI in these patients was 0.63 preoperatively and 0.85 at one year's follow-up. Three patients did not attend the control examination: one patient was in avery poor general condition and did not wish to attend the follow-up, and 2patients did not come to the one-year control despite several calls, the reason for which remained unknown. None of them suffered from critical limb ischemia at that time: eight patients wereasymptomatic and five had claudication. In one-year triplex control, six patients had restenosis of 0-50% in the PTA-treated arterial segment, and seven patients had 51-99% restenosis. No occlusions wereo bserved. Among the 13 patients who underwent one-year follow-up, ABI had increased from the preoperative 0.56 to 0.86 at one year's follow-up. 21 patients did not undergo oneyear follow-up: seven patients had died, six patients underwent an amputation, and bypass surgery was performed on five patients. Three patients did not observe the invitation to attend the control examination, one of whom was in institutional health care and in avery poor condition at the time.
PTALEVEL
Results according to anatomic level of PTAare presented in Table 3 .
QUALITy OF LIFE
Quality of life was measured preoperatively,a t3 0 days' follow-up and at one year's follow-up. There wereonly 14 claudicants and 7CLI patients who answered the questions on all occasions. In Table 4the means in each subgroup arecompared to the mean of the population (value in the first column), and significant differences aref ound. The 36 different tests have not been combined; the results have been interpreted separately.T he last three columns represent the significances of the pairwise comparisons in the general linear models for repeated measures, comparing the values at three different points in time. In the domains of energy and pain, claudicants seemed to improve their value after one month, but these changes werenot quite statistically significant, and at one year's follow-up, the scores weres ignificantly worse than at one month's follow-up. For both claudicants and CLI patients, the mean value for energy is even worse at one year's follow-up than preoperatively,but thedifference is not statistically significant. For CLI patients, improvement was seen in the domain of pain, which continued at both follow-up points, and the differencewas statistically significant between the one-year follow-up and the preoperative score. In the domain of sleep, therew as significant improvement for claudicants at one month's followup, and it continued until the one-year follow-up was concluded. For CLI patients, the improvement was not so clear,b ut they also reported significantly improved values at one year's follow-up than preoperatively.Among claudicants, the domain of physical mobility was significantly better at the one-month point than preoperatively,but at the one-year followup, the improvement had nearly disappeared and the scorew as no longer significantly better than preoperatively.
DISCUSSION
The role of PTAinthe treatment of limb-threatening ischaemia has increased significantly during the last five years. At the end of the last decade, the general opinion was that the PTAshould not be considered as ap rimary treatment for CLI except in extraordinary circumstances (7). The effectiveness of PTAi n the treatment in aortoiliac occlusive disease and claudication has been well established since the early 1990s (8,9). The enthusiasm towards PTAdue to improvements in endovascular technology and expertise has led to suggestions that PTAshould be the first choice for most of the patients requiring lower-extremity revascularization (10) (11) (12) . In patients with claudication and relatively short lesions in arteries proximal to the popliteal artery,t he clinical benefits of PTAcompared to bypass surgery areclear: thereis no need for general or spinal anaesthesia, the disadvantages of reconstructive surgery including surgical wounds areavoided, the hospital stay is shorter and 1 mean in age matched control population 2 P-value in testing difference between mean and control 1 value the rates of complications and mortality arelow. (12, 13) . However,t he role of PTAfor CLI is still controversial. Furthermore, an aspect that is at least as important as technical success and patency for claudication patients is the change in the quality of life of these patients. The technical success of PTAp rocedures is high and the clinical result of the treatment can be measured in an objective manner by noninvasive methods. In the current study,t he technical success was 100%,a nd postoperative complications werer are. Only one patients sustained as erious complication, stroke, and he recovered well with no permanent symptoms. Furthermore, the clinical success for claudication patients was good: only 1PTA segment was occluded at one-year follow-up and moret han 80% of patients werefreeofclaudication.
Patients with critical limb ischemia (CLI) differ significantly from those suffering from claudication. CLI-patients may have aw idespread atherosclerotic disease and serious risks regarding open surgery.On theother hand, some CLI patients may be suitable for both endovascular and open reconstructive treatment. As awhole, the present study demonstrates the poor outcome of CLI patients with high mortality and morbidity rates. However,o ne thirdo ft he CLI patients survived with no critical ischemia at one-year follow up. Those patients with rest pain seem to gain more benefit, whereas the outcome was poorer in legs with tissue loss.
Proof of the efficacy of the procedurehas been requested, as the current evidence regarding QoL following PTAi se quivocal especially among claudicants (14, 15) . Several generic quality of life instruments have recently been tested and used among vascular surgery patients. In this study,N HP was chosen, because at the time when the study was initiated, it was one of the few instruments that had been translated into Finnish and valuated and validated for the Finnish population (6). The NHP has been shown to be reliable among vascular surgery patients in earlier studies (2). Klevsgårde ta l. (2) demonstrated that the NHP was better than the Short-Form 36 Health Survey (SF-36) for patients with lower limb ischaemia with regardtopain and physical mobility and our experience is that the NHP was very effective in those domains.
Filling out the NHP questionnairei ndependently proved to be difficult or even impossible for many of ourp atients especially among the CLI-patients who areolder and whose moreserious illness causes varying levels of disability.P roblems with reading or writing arer eflected in the willingness to fill out a long questionnaire. Some of he NHP questions involving the domain of social isolation caused embarrassment to the patients and the results of the questionnairei nt hat domain aren ot reliable. Chronic neurologicalb rain diseases such as dementia and Alzheimer's disease makes the evaluation of the quality of life impossible with any questionnaires. Because of these problems, we had to exclude improperly filled out forms, which has caused some selection in our results.
The responses in the domains of energy,sleep, pain and physical mobility weremorer eliable than those given with reference to emotional reactions and social isolation. Our assessment is that patients found it easier to answer these questions. Because therewere only 11 patients with CLI at one-year follow-up who werea ble to answer the questions, the differences between the mean values did not reach statistical significance. In the domain of energy,a ni mprovement could be seen in both groups, CLI and claudication, butthis was statistically significant only for the claudicants. This improvement disappeared during the following year, and indeed the value worsened compared to the preoperative situation. The same phenomenon could be seeni nt he domain of pain for claudicants. One explanation might be that the disappearance of claudication pain improved the value at the one-month control but the patients forgot this benefit during the following year.T he patients suffered from many other co-morbidities that affected the results in the domain of energy.I nC LI patients, the scores in the domain of pain improved postoperatively and the improvement continued up to the one-year control. The improvement was statistically significant when the preoperative scores and the situation at one-year's follow-up werecompared.
In the domain of physical mobility,t he improvement for claudicants was clear and statistically significant up to the one-month follow-up, but again this improvement nearly disappeared during the following year.Inthe CLI group, therewerenochanges in the QoL value of mobility,which can be understood in that poor general health in CLI patients causes immobility along with limb ischemia and although leg salvage is achieved, patients stay relatively immobile.
The role of PTAi nt he treatment of CLI remains unclear.Inthe present data, the one-year outcome of CLI patients was relatively poor.Morbidity and mortality arelow after endovascular procedures, but the risks and the rate of complications are high, including cardiac events and local morbidity (11, 12, 16) . Thereforeitisasignificant finding that asubgroup of CLI patients gained aclear improvement which remained one year after PTA.
Claudication patients areg enerally believed to benefit from PTA. Although our one year clinical results and technical success weregood, as almost 90% of the patients werefreefromclaudication, the quality of life seemed to have deteriorated to the preoperative level with regardt ot he domains of pain and physical mobility.W hyman et al. (17) reported no correlation between improved ABI, walking distance and quality of life scorea t6m onths, except with regardtopain, among claudicants treated with angioplasty.C hetter et al.
(1) similarly observed in their study that unilateral claudicants undergoing PTAonasolitary iliac lesion demonstrated the most marked QoL benefits and, 12 months post-PTA, reported aQ oL approaching that of an age-matched population. In contrast, Klevsgård( 2) reported that successful treatment of chronic limb ischaemia improved the quality of life for claudicants in their sixmonth follow up study. Discrepancies between the technical success of PTA, improvement in Fontaine classification and long-term improvement in the quality of life indicates that therea re no reliable methods to analyse the effects of PTA-procedures in the treatment of claudication. Our study raises the question whether the treatment of claudication provides any long term improvement in quality of life.
